Boston Scientific (BSX) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Goldman Sachs Upgrades Boston Scientific (BSX) to Neutral
October 23, 2014 6:44 AM EDTGoldman Sachs upgraded Boston Scientific (NYSE: BSX) from Sell to Neutral with a price target of $13.00 (from $11.00).
Analyst David H. Roman said, "We upgrade shares of Boston Scientific (BSX) to Neutral from Sell, given what looks to be higher sustainable growth and more... More
Benchmark Upgrades Boston Scientific (BSX) to Buy
October 22, 2014 2:17 PM EDTBenchmark upgraded Boston Scientific (NYSE: BSX) from Hold to Buy with a price target of $15.00.
For an analyst ratings summary and ratings history on Boston Scientific click here. For more ratings news on Boston Scientific click here.
Shares of Boston Scientific closed at $12.03 yesterday.
... More